Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9306 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9172 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.906 |
High Similarity |
NPD7411 |
Suspended |
0.8889 |
High Similarity |
NPD7075 |
Discontinued |
0.8819 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8819 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD7819 |
Suspended |
0.8767 |
High Similarity |
NPD3750 |
Approved |
0.8766 |
High Similarity |
NPD3749 |
Approved |
0.8759 |
High Similarity |
NPD1549 |
Phase 2 |
0.8758 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD4380 |
Phase 2 |
0.8693 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8681 |
High Similarity |
NPD1510 |
Phase 2 |
0.8671 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD6801 |
Discontinued |
0.8621 |
High Similarity |
NPD2796 |
Approved |
0.8581 |
High Similarity |
NPD7768 |
Phase 2 |
0.8571 |
High Similarity |
NPD1243 |
Approved |
0.8531 |
High Similarity |
NPD1240 |
Approved |
0.8526 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8467 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8446 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8414 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8395 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8392 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8387 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8378 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8333 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8322 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8301 |
Intermediate Similarity |
NPD920 |
Approved |
0.8299 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.828 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8264 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8243 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8243 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8219 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8219 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD5403 |
Approved |
0.817 |
Intermediate Similarity |
NPD2532 |
Approved |
0.817 |
Intermediate Similarity |
NPD2534 |
Approved |
0.817 |
Intermediate Similarity |
NPD2533 |
Approved |
0.817 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8169 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8138 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8113 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8098 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8077 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8072 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8061 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8054 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.8052 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8049 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8041 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8026 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8012 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7976 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7964 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7958 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7952 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7933 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD919 |
Approved |
0.7892 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7891 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7881 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7877 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7875 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.787 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.787 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7803 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7799 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7793 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7792 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7785 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.774 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7716 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD5890 |
Approved |
0.764 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7628 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7627 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7595 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.755 |
Intermediate Similarity |
NPD943 |
Approved |
0.7533 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7533 |
Intermediate Similarity |
NPD411 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD447 |
Suspended |
0.75 |
Intermediate Similarity |
NPD1933 |
Approved |
0.75 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7452 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7432 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7379 |
Intermediate Similarity |
NPD17 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7361 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7343 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7314 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7314 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7294 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD7585 |
Approved |
0.723 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7184 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7162 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7095 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7095
|
Intermediate Similarity |
NPD8434 |
Phase 2 |